Major variation for application Roszdravnadzor-2021-0079. Major variation: Facility Change for Atezolimumab-R — major revision

Variation Number
Roszdravnadzor-2021-0079-V479
Type
Major
Status
In Progress
Fee
€79,312
Submitted
2023-07-11
Approved
—
Description

Major variation: Facility Change for Atezolimumab-R — major revision